Arno Therapeutics, Inc·4

Oct 31, 7:47 PM ET

Arno Therapeutics, Inc 4

4 · Arno Therapeutics, Inc · Filed Oct 31, 2013

Insider Transaction Report

Form 4
Period: 2013-10-29
Transactions
  • Purchase

    Common Stock

    2013-10-29+20,83322,079 total
  • Purchase

    2013 Series D Warrants (right to buy)

    2013-10-29+20,83320,833 total
    Exercise: $4.00From: 2013-10-29Exp: 2018-10-29Common Stock (20,833 underlying)
  • Purchase

    2013 Series E Warrants (right to buy)

    2013-10-29+20,83320,833 total
    Exercise: $2.40From: 2013-10-29Exp: 2014-10-31Common Stock (20,833 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $8.00Exp: 2019-09-29Common Stock (3,750 underlying)
    3,750
  • Stock Option (right to buy)

    Exercise: $8.00Exp: 2020-11-05Common Stock (1,250 underlying)
    1,250
Footnotes (3)
  • [F1]The reported securities are included within 20,833 Issuer units purchased by the Reporting Person for $2.40 per unit. Each unit consists of one share of common stock, a 2013 Series D Warrant to purchase one share of common stock, and a 2013 Series E Warrant to purchase one share of common stock.
  • [F2]Currently exercisable.
  • [F3]Vests in three equal annual installments commencing 11/5/11.

Documents

2 files
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    HAMILTON POWER OF ATTORNEY